Drug Profile
BII 001
Alternative Names: BII-001Latest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator Boryung Pharmaceutical
- Class Antifungals
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for phase-I development in Mycoses in South Korea
- 06 May 2016 Phase-I clinical trials in Mycoses in South Korea (unspecified route)